Identifying Molecular Drivers of Cancer
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/27/2018 |
| Start Date: | April 2014 |
| End Date: | May 22, 2018 |
The primary aim of this study is to identify drivers of cancer by performing comprehensive
genetic, proteomic, and metabolomic characterization of patient samples as a basis for
understanding the underlying cause of disease.
genetic, proteomic, and metabolomic characterization of patient samples as a basis for
understanding the underlying cause of disease.
This study involves looking at the DNA, RNA, proteins, and metabolites in blood and tissue
samples collected from subjects and linking them to their health information. By doing so,
researchers hope to discover the underlying molecular causes of human diseases with the hope
that this information can be used for the development of diagnostic tests and more effective
treatments.
samples collected from subjects and linking them to their health information. By doing so,
researchers hope to discover the underlying molecular causes of human diseases with the hope
that this information can be used for the development of diagnostic tests and more effective
treatments.
Inclusion Criteria:
- Patients diagnoses with cancer but healthy enough to undergo a biopsy procedure
- Between the ages of 18 and 100
Exclusion Criteria:
- Patients who are pregnant
We found this trial at
1
site
Avera Cancer Institute Avera, the health ministry of the Benedictine and Presentation Sisters, is a...
Click here to add this to my saved trials
